These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33767866)

  • 1. Tumor-infiltrating lymphocytes in tissue material combined with systemic lymphocyte inflammation in patients with colorectal cancer.
    Jakubowska K; Koda M; Grudzińska M; Lomperta K; Famulski W
    Mol Clin Oncol; 2021 May; 14(5):97. PubMed ID: 33767866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma.
    Jakubowska K; Kisielewski W; Kańczuga-Koda L; Koda M; Famulski W
    Oncol Lett; 2017 Dec; 14(6):6421-6432. PubMed ID: 29151905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases.
    Jakubowska K; Koda M; Kisielewski W; Kańczuga-Koda L; Famulski W
    Exp Ther Med; 2019 Dec; 18(6):4904-4912. PubMed ID: 31807155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the Role of Tumor-Infiltrating Lymphocytes as Predictors of Lymph Node Metastasis in Deep Submucosal Invasive Colorectal Cancer: A Retrospective Cross-Sectional Study.
    Tamari H; Kitadai Y; Takigawa H; Yuge R; Urabe Y; Shimamoto F; Oka S
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy.
    Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
    Sci Rep; 2019 Aug; 9(1):11617. PubMed ID: 31406179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
    Dirican N; Karakaya YA; Gunes S; Daloglu FT; Dirican A
    Clin Respir J; 2017 Nov; 11(6):789-796. PubMed ID: 26619201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.
    Luen SJ; Salgado R; Fox S; Savas P; Eng-Wong J; Clark E; Kiermaier A; Swain SM; Baselga J; Michiels S; Loi S
    Lancet Oncol; 2017 Jan; 18(1):52-62. PubMed ID: 27964843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.
    Araki K; Ito Y; Fukada I; Kobayashi K; Miyagawa Y; Imamura M; Kira A; Takatsuka Y; Egawa C; Suwa H; Ohno S; Miyoshi Y
    BMC Cancer; 2018 Oct; 18(1):982. PubMed ID: 30326862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of inflammatory cell infiltrates, tumor stroma percentage and disease-free survival in patients with colorectal cancer.
    Jakubowska K; Kisielewski W; Kańczuga-Koda L; Koda M; Famulski W
    Oncol Lett; 2017 Sep; 14(3):3869-3877. PubMed ID: 28927159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer.
    Goto R; Hirota Y; Aruga T; Horiguchi S; Miura S; Nakamura S; Takimoto M
    Breast Cancer; 2020 Jul; 27(4):586-593. PubMed ID: 31933123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Low Densities of FoxP3
    Cavalleri T; Bianchi P; Basso G; Celesti G; Grizzi F; Bossi P; Greco L; Pitrone C; Valtorta E; Mauri G; Truini M; Dall'Olio FG; Brandi G; Sartore-Bianchi A; Ricciardiello L; Torri V; Rimassa L; Siena S; Mantovani A; Malesci A; Laghi L;
    Cancer Immunol Res; 2019 May; 7(5):751-758. PubMed ID: 30804005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the Warburg effect in tumour cells and the tumour microenvironment in colorectal cancer patients: Results from a large multicentre study.
    Steeghs JPJM; Offermans K; Jenniskens JCA; Samarska I; Fazzi GE; van den Brandt PA; Grabsch HI
    Pathol Res Pract; 2023 Jul; 247():154518. PubMed ID: 37209573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer.
    Takada K; Kashiwagi S; Asano Y; Goto W; Kouhashi R; Yabumoto A; Morisaki T; Shibutani M; Takashima T; Fujita H; Hirakawa K; Ohira M
    BMC Cancer; 2020 Jun; 20(1):598. PubMed ID: 32590956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.
    Rouanne M; Betari R; Radulescu C; Goubar A; Signolle N; Neuzillet Y; Allory Y; Marabelle A; Adam J; Lebret T
    Eur J Cancer; 2019 Feb; 108():111-119. PubMed ID: 30654296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.
    Pruneri G; Vingiani A; Bagnardi V; Rotmensz N; De Rose A; Palazzo A; Colleoni AM; Goldhirsch A; Viale G
    Ann Oncol; 2016 Feb; 27(2):249-56. PubMed ID: 26598540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour infiltrating lymphocytes are predictors of lymph node metastasis in early gastric cancers.
    Kim JY; Kim CH; Lee Y; Lee JH; Chae YS
    Pathology; 2017 Oct; 49(6):589-595. PubMed ID: 28843920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.